Date: 2011-02-11
Type of information: Private placement
Company: Biotec Pharmacon (Norway)
Investors:
Amount: NOK 7.56 million
Funding type: private placement
Planned used:
Others: Reference is made to the announcement dated 23 December 2010 and the prospectus dated 27 January 2011 concerning the subsequent offering of up to 1,200,000 shares in Biotec Pharmacon ASA at a subscription price of NOK 6.30. The subsequent offering ended on Thursday 10 February 2011 at 17:30 CET, and was significantly oversubscribed. As a result, Biotec Pharmacon will issue 1,200,000 new shares at NOK 6.30 per share raising gross proceeds of NOK 7.56 million. All subscribers being allotted offer shares will receive a letter confirming the number of offer shares allotted to the subscriber and the corresponding amount to be paid. This letter will be distributed shortly. Payment of the shares will fall due on 17 February 2011 and delivery will take place on or about 22 February 2011. Following registration of the shares the total number of issued shares will increase by 1,200,000, from 27,137,910 to 28,337,910 shares.
Therapeutic area:
